Trial Profile
A 7-week Phase III trial of diclofenac gel (Pennsaid 2%) in Russia
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 10 Nov 2015
Price :
$35
*
At a glance
- Drugs Diclofenac (Primary)
- Indications Osteoarthritis
- Focus Registrational; Therapeutic Use
- Sponsors NovaMedica
- 05 Nov 2015 According to Nuvo Research media release, this study met required endpoints.
- 05 Nov 2015 Status changed from recruiting to completed, as per Nuvo Research media release.
- 16 Mar 2015 New trial record